Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2015
Pharma News, 2015
LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis
LEO Pharma Inc.
New Discovery About Fructose Could Lead To Treatments For Cancer, Obesity And Diabetes
Scientists have discovered how one sugar – fructose – is transported into our cells.
AHF Calls on President Obama to Withdraw Dr. Robert Califf as Nominee to Head FDA
LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), which previously criticized FDA Commissioner nominee Dr.
Obama nominates Robert Califf as FDA commissioner
President Barack Obama has nominated Dr.
Baricitinib Demonstrates Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis in Pivotal Phase 3 Study
INDIANAPOLIS, IN, USA I October 14, 2015.
Savolitinib completes enrolment for Phase II clinical trial in Papillary Renal Cell Carcinoma
Shanghai.
Zafgen Issues Statement: Patient Died During Beloranib Trial
BOSTON, Oct.
Valeant under US federal investigation over drug pricing
Canadian pharmaceutical group Valeant says it has received subpoenas from US federal prosecutors seeking information about the pricing and distribution of its drugs, along with how it makes them more ...
J&J says it has plenty of firepower for M&A, buyback or no buyback
Johnson & Johnson ($JNJ) may be embarking on a $10 billion share repurchase program, but that doesn't mean it doesn't have room to make deals.
Danish malaria vaccine discovery provides potential cancer cure
COPENHAGEN, Oct.
Former Merck Analyst Gets Three Years for Insider Trading
A former Merck & Co.
aTyr Pharma Initiates Phase 1b/2 Clinical Trial for Patients with Limb Girdle Muscular Dystrophy 2B
SAN DIEGO, Oct.
9
10
11
12
13
14
15
16
17
